A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis.
作者信息
Henderson Lauren A
机构信息
Boston Children's Hospital, Boston, Massachusetts.
出版信息
Arthritis Rheumatol. 2019 Jul;71(7):1030-1033. doi: 10.1002/art.40867. Epub 2019 May 27.
Abstract
摘要
相似文献
1
A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis.系统性幼年特发性关节炎患儿的靶心
Arthritis Rheumatol. 2019 Jul;71(7):1030-1033. doi: 10.1002/art.40867. Epub 2019 May 27.
2
Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis.社论：迈向系统性幼年特发性关节炎的个性化治疗
Arthritis Rheumatol. 2018 Aug;70(8):1172-1174. doi: 10.1002/art.40501. Epub 2018 Jun 29.
3
PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY.一名接受免疫抑制治疗的青少年系统性幼年特发性关节炎患者出现的心前区疼痛、白细胞增多和双细胞减少症
Rev Paul Pediatr. 2019 Apr-Jun;37(2):252-256. doi: 10.1590/1984-0462/;2019;37;2;00004. Epub 2019 Feb 25.
4
Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis.白细胞介素6作为全身型幼年特发性关节炎的治疗靶点
Curr Opin Rheumatol. 2003 Sep;15(5):581-6. doi: 10.1097/00002281-200309000-00010.
5
Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus.他克莫司治疗难治性多关节型幼年特发性关节炎
Rheumatology (Oxford). 2014 Nov;53(11):2120-2. doi: 10.1093/rheumatology/keu297. Epub 2014 Jul 26.
6
Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus.他克莫司治疗全身型幼年特发性关节炎的疑难病例
Eur J Pediatr. 2007 Oct;166(10):1053-5. doi: 10.1007/s00431-006-0380-0. Epub 2006 Dec 23.
7
Positron emission tomography findings in systemic juvenile idiopathic arthritis.
Rheumatology (Oxford). 2011 Jun;50(6):1177. doi: 10.1093/rheumatology/ker136. Epub 2011 Mar 29.
8
Systemic Juvenile Idiopathic Arthritis.全身型幼年特发性关节炎
Pediatr Clin North Am. 2018 Aug;65(4):691-709. doi: 10.1016/j.pcl.2018.04.005.
9
Systemic-onset juvenile idiopathic arthritis.全身型幼年特发性关节炎。
Autoimmun Rev. 2016 Sep;15(9):931-4. doi: 10.1016/j.autrev.2016.07.004. Epub 2016 Jul 6.
10
Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).系统性幼年特发性关节炎初始治疗四种共识治疗方案的贝叶斯比较有效性研究：系统性幼年特发性关节炎治疗的一线选择（FROST）
Clin Trials. 2018 Jun;15(3):268-277. doi: 10.1177/1740774518761367. Epub 2018 Mar 15.
引用本文的文献
1
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.白细胞介素-1阻断剂治疗全身型幼年特发性关节炎的经验——来自德国AID注册中心的数据。
Pediatr Rheumatol Online J. 2021 Mar 22;19(1):38. doi: 10.1186/s12969-021-00510-8.
本文引用的文献
1
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.迈向幼年特发性关节炎新分类标准：初步步骤，儿科风湿病学国际试验组织国际共识。
J Rheumatol. 2019 Feb;46(2):190-197. doi: 10.3899/jrheum.180168. Epub 2018 Oct 1.
2
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.德国系统性幼年特发性关节炎诊断与管理中的实践及基于共识的策略
Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7. doi: 10.1186/s12969-018-0224-2.
3
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.BIKER 登记研究中依那西普、托珠单抗和白细胞介素-1 抑制剂治疗全身型幼年特发性关节炎患者的经验。
Arthritis Res Ther. 2017 Nov 22;19(1):256. doi: 10.1186/s13075-017-1462-2.
4
Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.2000-2013 年德国国家儿科风湿病数据库中全身性幼年特发性关节炎的治疗结果和趋势。
Arthritis Rheumatol. 2016 Dec;68(12):3023-3034. doi: 10.1002/art.39796.
5
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.儿童关节炎与风湿病研究联盟登记处的系统性幼年特发性关节炎队列研究：2010 - 2013年
J Rheumatol. 2016 Sep;43(9):1755-62. doi: 10.3899/jrheum.150997. Epub 2016 Jun 15.
6
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.一线治疗用重组白细胞介素-1 受体拮抗剂治疗新诊断的全身型幼年特发性关节炎的无激素初治患者的疗效：一项前瞻性队列研究的结果。
Arthritis Rheumatol. 2014 Apr;66(4):1034-43. doi: 10.1002/art.38296.
7
Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?综述：治疗全身型幼年特发性关节炎是否存在治疗时机窗？
Arthritis Rheumatol. 2014 Jun;66(6):1405-13. doi: 10.1002/art.38615.
8
2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.2011年美国风湿病学会关于幼年特发性关节炎治疗建议的2013年更新：针对全身型幼年特发性关节炎患儿的药物治疗建议以及接受生物制剂治疗儿童的结核病筛查。
Arthritis Rheum. 2013 Oct;65(10):2499-512. doi: 10.1002/art.38092.
9
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.两项卡那单抗治疗全身型幼年特发性关节炎的随机临床试验。
N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099.
10
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.托珠单抗治疗全身型幼年特发性关节炎的随机临床试验。
N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802.
Zotero 插件